Loading
Latest filing published 16 Oct 2026 for Beam Therapeutics Inc., €535k.
All filings by John M Evans on record concern Beam Therapeutics Inc. In total, 4 filings cover trades dated from 29 June 2026 to 16 October 2026.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
The newest entry dates from 16 October 2026: a transaction of €535k, in Beam Therapeutics Inc. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 of 4 declarations